Variable | Statin group (n = 70) | No statin group (n = 40) | p value |
---|---|---|---|
Age | 58.1 ± 11.6 | 52.3 ± 12.2 | 0.016a |
Sex (male:female) | 41:29 | 17:23 | 0.104 |
Duration of diabetes mellitus (years) | 12.4 ± 8.0 | 8.6 ± 8.2 | 0.019a |
Follow-up period (months) | 26.8 ± 16.9 | 22.9 ± 15.4 | 0.251 |
Presence of hypertension | 56/70 (80%) | 26/40 (65%) | 0.082 |
Initial DR severity scale | Â | Â | 0.445 |
 Mild NPDR (20–35) | 17 | 5 |  |
 Mod-severe NPDR (43–53) | 50 | 30 |  |
 PDR (more than 61) | 3 | 5 |  |
DR progression (≥2 steps of DRSS) | 16/70 (23%) | 7/40 (18%) | 0.506 |
Presence of diabetic macular edema | 16/70 (23%) | 19/40 (48%) | 0.008a |
No. of IVT | 1.2 ± 2.4 | 1.8 ± 3.0 | 0.317 |
HbA1c (%) | 8.1 ± 1.7 | 8.0 ± 1.5 | 0.758 |
Total cholesterol (mmol/L) | 4.4 ± 2.6 | 4.4 ± 1.5 | 0.904 |
Triglycerides (mmol/L) | 1.9 ± 1.4 | 2.1 ± 1.5 | 0.569 |
HDL cholesterol (mmol/L) | 1.1 ± 0.3 | 1.1 ± 0.3 | 0.990 |
LDL cholesterol (mmol/L) | 2.1 ± 0.8 | 3.0 ± 1.3 | 0.007a |